Alphabet Shares Hit New All-Time Highs After NVIDIA H100 Surpasses Google TPUs
What Is Passive Income and Why It Matters
Alphabet Tops Overbought List in CNBC's 2025 Market Snapshot
Housing Prices Soar While Young Canadians Turn to Stock Market
HDFC Bank Eyes 18% Profit Surge Amid Strong Loan Growth and Digital Initiatives
Alphabet Achieves Resounding Victory in Competitive Tech Landscape
Small-Cap Funds in 2025: How Much to Allocate, When to Enter, and What to Avoid
GMO warns AI valuations resemble classic bubble, advises cautious approach
New Mountain Finance's NAV Slides 12% in Q3, Prompting S&P Downgrade
UK Government Bans Transfers From Stocks-and-Shares ISAs to Cash ISAs
Tech Stocks vs. Traditional Industries: Balancing Innovation and Stability in 2025
Intel Surges with 7nm Strategy
SanDisk Earns S&P 500 Spot, Elevating Its Market Profile
Oracle Eyes AI Surge: Analysts Predict High-Growth Momentum
Riot Platforms: A High-Leverage Bitcoin Miner Facing Debt and Regulatory Risks
2025 Market Forecast: AI Bubble, Macro Headwinds and Non-AI Defensive Picks
Waste Management: A Defensive Core Holding with Undervalued Growth Potential
No. 1 Holding: Robinhood Dumped by Retail Investors
Dhanarthi: Democratizing Fundamental Stock Analysis for Everyday Investors
Why Rebalancing Matters When the Market Is At Record Highs
ChatGPT Now Allowed to Provide General Investment Guidance
Michael Burry Bets Big on AI: Nvidia, Meta, Oracle and the Hyperscalers
CalPERS Incurs $80 Million Loss on $600 Million Strategic Allocation
Thanksgiving Trading Alert: Avoid the 'Turkey Trap' in Big-Tech Stocks
Tesla's 500,000-Annual Production & 4680 Battery Cells Spark 50% Upside Potential
India's LRS Outflows Surpass INR2 Billion Amid 55% Surge in 2025
Dusty May Urges Wolverines to Maximize NIL Earnings Through Smart Investments
The Secret to Stock-Ownership Happiness, According to Warren Buffett
Modiv Industrial: A Monthly-Dividend REIT Poised to Ride Tariff & Supply-Chain Shifts
Three Dividend Stocks I'm Thankful for This Year: A Detailed Summary
OakTree Specialty Lending BDC Faces Inevitable Pricing Decline
A Quick Guide to Four Dividend-Heavy Picks for the Next Five Years
Locale: UNITED STATES

A Quick Guide to Four Dividend‑Heavy Picks for the Next Five Years
If you’re sitting on a tidy $2,000 that you want to grow over the next half‑decade, you’re not alone. In the current environment, investors are increasingly turning to “income” stocks—companies that not only pay out cash to shareholders but also demonstrate a track record of steadily raising those payouts. The MSN Money article “Have $2000 to invest? Here are 4 of my favorite dividend stocks for the next 5 years” breaks down four solid options that blend reliability with modest growth potential.
Below is a concise summary of the main points, including the key facts for each stock and why the author believes they’re worth a spot in a long‑term portfolio. (If you want more depth on any one of the companies or the mechanics of dividend investing, the article contains handy links to the SEC filings, 10‑K reports, and a couple of explanatory sidebars on dividend yields and payout ratios.)
1. 3M Co. (MMM)
Sector – Industrial/Consumer Goods
Current Yield – ~4.5%
Payout Ratio – ~60%
5‑Year Dividend Growth – 13% per year (compound)
Why 3M?
The author highlights 3M’s legacy of innovation—think Post‑its, Scotch Tape, and its diverse portfolio of safety, healthcare, and electronics products. Because the company’s revenues are spread across more than 70 business segments, it can weather sector‑specific downturns. The 60% payout ratio suggests there’s ample room for the firm to increase dividends while still retaining enough cash to fund R&D and capital expenditures.
Investment Takeaway
With a price hovering around $190, a $2,000 investment would buy roughly 10.5 shares, yielding about $90 in quarterly cash. Over five years, assuming a 13% dividend growth rate, that cash stream could compound into an extra $250 just from reinvested dividends—if you choose to roll them back into more shares.
2. Procter & Gamble Co. (PG)
Sector – Consumer Staples
Current Yield – ~2.8%
Payout Ratio – ~71%
5‑Year Dividend Growth – 7% per year (compound)
Why PG?
PG’s brand portfolio—brands such as Tide, Pampers, and Gillette—offers “sticky” demand; consumers keep buying these everyday products even during recessions. The company’s disciplined cash‑flow management has allowed it to sustain a 2.8% yield while still maintaining a generous payout ratio. The article notes that PG’s dividend history dates back over 60 years, earning it a spot on the Dividend Aristocrats list.
Investment Takeaway
At a price near $140, a $2,000 stake nets you about 14.3 shares and $40 in quarterly dividends. The author recommends buying in tranches—say, 4 equal purchases over the next 12 months—to smooth out price volatility and capture any intraday dips.
3. Coca‑Cola Co. (KO)
Sector – Consumer Staples
Current Yield – ~3.1%
Payout Ratio – ~76%
5‑Year Dividend Growth – 6% per year (compound)
Why KO?
KO’s iconic beverage brand portfolio (Coca‑Cola, Diet Coke, Sprite, Fanta) is coupled with a global distribution network that keeps margins high. Even as the company faces competition from healthier drink options, its advertising spend and brand loyalty keep the demand curve relatively inelastic. The article notes KO’s strategic shift toward premium beverages and a growing “hard seltzer” line that should sustain revenue growth.
Investment Takeaway
With the stock trading at roughly $58, your $2,000 would buy about 34.5 shares, translating to ~$40 in quarterly dividends. Because KO’s payout ratio is a bit on the high side, the author cautions that the company could face a dividend cut if earnings were to dip sharply—so monitoring earnings releases is key.
4. Johnson & Johnson (JNJ)
Sector – Healthcare/Consumer Staples
Current Yield – ~2.6%
Payout Ratio – ~61%
5‑Year Dividend Growth – 8% per year (compound)
Why JNJ?
JNJ’s diversified business model includes pharmaceuticals, medical devices, and consumer health products (e.g., Tylenol, Band‑Aid). The author highlights its strong pipeline of generic drugs and its aggressive acquisition strategy in the device space. JNJ’s conservative payout ratio combined with a robust dividend history makes it a “safe haven” for dividend investors, especially when the macro environment becomes uncertain.
Investment Takeaway
At about $170 per share, $2,000 buys ~11.8 shares, yielding roughly $35 in quarterly cash. The article suggests pairing JNJ with an “income” strategy: buying when the share dips below the 50‑day moving average and holding for at least three years to capture dividend reinvestment growth.
Key Themes the Article Highlights
Dividend Aristocrats and Dividend Kings – All four companies are members of these lists, which means they’ve raised dividends for at least 25 and 50 consecutive years, respectively. The author argues that this track record is a strong signal of management discipline.
Reinvestment Over Leverage – The article explicitly discourages taking on debt to buy these shares. Instead, it recommends allocating the $2,000 to a brokerage account that offers a dividend reinvestment plan (DRIP). This allows the investor to compound earnings automatically without additional fees.
Diversification Even Within Income – By picking companies from industrial, consumer staples, beverage, and healthcare sectors, the portfolio is less likely to be hurt by a downturn in a single industry.
Monitoring Payout Ratios – A payout ratio that is too high (typically > 80%) can be a warning sign that the company might need to cut dividends if earnings slow. The author underscores the importance of watching this ratio in each earnings report.
Tax Considerations – The article reminds readers that dividends are taxable, but qualified dividends are taxed at a lower rate than ordinary income. Holding the shares in a tax‑advantaged account (e.g., an IRA) can maximize after‑tax returns.
How to Start Investing
Step 1: Choose a Brokerage – Pick a platform that offers zero‑commission trading and a free DRIP. Many of the article’s links point to brokerages such as Fidelity, Charles Schwab, or Vanguard.
Step 2: Open a Tax‑Advantaged Account – If you’re in a lower tax bracket, an IRA can be ideal. If you prefer a taxable account, look for a broker that offers paper‑less dividends and a clean record of handling dividends for you.
Step 3: Allocate Your $2,000 – One strategy is to split the amount equally among the four stocks ($500 each). Alternatively, you could favor the high‑yield stocks (MMM, KO) and invest the rest in the lower‑yield but higher‑growth options (PG, JNJ).
Step 4: Set Up Automatic Deposits – Even if you only have $2,000 now, adding $200 a month keeps your investment growing steadily and takes advantage of dollar‑cost averaging.
Step 5: Keep an Eye on Earnings and Payouts – The article links to each company’s investor relations pages. Bookmark those for quarterly reports and dividend announcements.
Bottom Line
The MSN Money piece offers a clear, beginner‑friendly blueprint for using a modest sum of cash to build a portfolio that can deliver steady cash flow and modest capital appreciation over the next five years. By focusing on companies with long‑standing dividend growth, solid payout ratios, and diversified revenue streams, the author shows how a $2,000 investment can be stretched to provide regular income and the compounding benefits of reinvested dividends. If you’re looking to enter the world of dividend investing without over‑complicating things, these four stocks—3M, Procter & Gamble, Coca‑Cola, and Johnson & Johnson—offer a solid starting point.
Read the Full The Motley Fool Article at:
[ https://www.msn.com/en-us/money/topstocks/have-2000-to-invest-here-are-4-of-my-favorite-dividend-stocks-for-the-next-5-years/ar-AA1RfTzr ]
Turn $2,500 into $4,000 a Year: A Dividend Income Blueprint
Johnson & Johnson: 52 Years of Dividend Growth and 2.8% Yield
Microsoft and Visa: Dividend-Paying Growth Stocks for 2025
Build a $5,000 Dividend Portfolio with 4 Dividend Aristocrats
November 2025 Dividend Picks: PG, JNJ, and NextEra Lead the Charge
November 2025 High-Yield Playbook: The Top Dividend Stars in the S&P 500